OS Therapies
OSTX
30 hedge funds and large institutions have $4.09M invested in OS Therapies in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 6 closing their positions.
482% more capital inflows, than outflows
Capital inflows: $1.7M | Capital outflows: $292K
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
15% more funds holding
Funds holding: 26 → 30 (+4)
3.19% more ownership
Funds ownership: 5.05% → 8.23% (+3.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$637K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$469K |
| 3 |
Howard Financial Services
Dallas,
Texas
|
+$348K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$48.3K |
| 5 |
State Street
Boston,
Massachusetts
|
+$46.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$154K |
| 2 |
Two Sigma Investments
New York
|
-$86.8K |
| 3 |
Millennium Management
New York
|
-$43.1K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$7.46K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
OSTX Hedge Fund Activity: Q1 2026 in Review
30 of the 8,241 institutional investors tracked by Wall St. Rank reported a position in OS Therapies (OSTX) for Q1 2026, worth a combined $4.09M — up 64% from $2.49M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new OSTX positions and 6 closed out — a net gain of 1 holder — while 7 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $637K. The largest seller was Marshall Wace, exiting entirely with an estimated $154K sold.
- 30 institutional investors held OS Therapies (OSTX) as of Q1 2026, up from 26 in Q4 2025.
- Funds reported $4.09M of OS Therapies stock for Q1 2026, up 64% quarter-over-quarter.
- 7 funds opened new OS Therapies positions in Q1 2026 and 6 closed out, a net change of +1 holder.
- The largest OS Therapies buyer in Q1 2026 was Susquehanna International Group, an estimated $637K added.
- The largest OS Therapies seller in Q1 2026 was Marshall Wace, an estimated $154K sold.
Based on aggregated 13F filings for Q1 2026.